US$ 29.16
glp-1 for ckd and the kidney: from physiology to pharmacology and outcomes in diabetes CKJ REVIEW GLP-1 receptor agonists
Description
N Engl J Med (2016) 375(19):183444
Bruce Bauer in Chicago

[archived link] Link to Original Substack Post

Ta deg tid til se helheten: kvaliteten p spillene, klare vilkr, raske utbetalinger og gode verkty for ansvarlig spilling

These results build excitement and encourage continued effort

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial
